Wilson disease in a Nigerian child: a case report
© Esezobor et al.; licensee BioMed Central Ltd. 2012
Received: 30 January 2012
Accepted: 21 May 2012
Published: 16 July 2012
Wilson disease is rarely reported among African children. This report describes the second case report of a Nigerian child with Wilson disease in three decades.
An eight-year-old African boy presented with generalized oedema and ascites and proteinuria. Over the next three weeks he developed conjugated hyperbilirubinaemia, severe coagulopathy and prominent extrapyramidal features consisting of rigidity, tremors at rest and in action, shuffling gait, slurred speech and emotional lability. Slit-lamp examination of his eyes revealed Kayser-Fleischer rings and sunflower cataracts. His serum caeruloplasmin level was 5mg/dL. Using the scoring system proposed by the 8th International Meeting of Wilson Disease and Menkes Disease, a diagnosis of Wilson disease was made.
Wilson disease does occur in African children, although the diagnosis is rarely made. A diagnosis of Wilson disease should be entertained in the evaluation of African children presenting with liver dysfunction and/or extrapyramidal neurological features.
Wilson Disease (WD) is a rare autosomal recessive disease resulting in a systemic overload of copper. The reported prevalence is 30 per million people . However, apart from a report three decades ago, WD has not been described in children in Nigeria . In this report we describe another Nigerian child with WD and highlight that, though uncommonly diagnosed in African children, WD should also be considered in the differential diagnosis of a clinical presentation of liver disease and/or extrapyramidal manifestation in children in Africa.
An eight-year-old African boy, previously well, was referred to our unit on account of nephrotic syndrome. He had presented to our emergency department a day before with ascites, facial swelling and reduced urinary output in the preceding two weeks. After two days of hospitalization, he became deeply jaundiced with worsening of the generalized oedema. A day later, he had three brief episodes of generalized clonic seizures over a two-hour period and became increasingly drowsy. The seizures were aborted with diazepam and he remained seizure-free after a short course of phenobarbitone. A physical examination did not support a diagnosis of meningitis and other aspects of a neurological examination were normal. He had ascites and non-tender hepatomegaly; his spleen was not palpable. A review of his history did not reveal chronic or recent use of orthodox or non-orthodox medicines. In addition, there was no previous or current history of similar illness in his four siblings and close contacts. Both his parents were Africans, of the Igbo ethnic group from southeast Nigeria, but were not known to be blood relatives.
Results of liver function tests of the boy during hospitalization
Serum bilirubin: Total, Direct (mg/dL)
Serum protein (mg/dL)
Serum albumin (mg/dL)
Serum alanine transaminase (IU/L)
Serum aspartate transaminase (IU/L)
Serum alkaline phosphatase (IU/L)
Serum gamma-glutamyltransferase (IU/L)
Plasma thromboplastin: Test, Control (sec)
Prothrombin time: Test, Control (sec)
International normalized ratio
Using the scoring system proposed by the 8th International Meeting of Wilson Disease and Menkes Disease , our patient achieved a score of 6 (compatible neuropsychiatric features = 2; K-F rings = 2 and caeruloplasmin level of 5mg/dL =2) and a diagnosis of WD was made.
His diet was restricted to high calorie, low protein and low copper meals. Vitamins, including vitamin K, and lactulose and neomycin were commenced. Control of the generalized oedema was achieved with furosemide and spironolactone. Long-term zinc and pyridoxine therapy was started. The use of trihexyphenidyl helped achieved some control of the spasticity and rigidity, sufficient to allow resumption of basic activities such as walking and holding objects. His liver dysfunction also improved, with near resolution of the international normalized ratio (from 12 to 4).
WD is a rare autosomal recessive disorder resulting in copper overload. Most cases have been reported in developed countries [4–6]. Apart from North Africa, where several cases of WD have been described, the diagnosis is rarely made in children and adults in Africa [7–9]. The higher frequency of detection in North Africa compared with the rest of Africa may be explained by the higher rate of consanguinity in North Africa, which makes an autosomal recessive disease more likely to occur .
Children with WD are usually normal at birth and may remain healthy for a variable period of time; most cases present in the second and third decade of life . Our patient had conjugated hyperbilirubinaemia, ascites and severe dysfunction of the synthetic activity of his liver. Although he had proteinuria and generalized oedema, which informed the initial diagnosis of nephrotic syndrome, the proteinuria never reached nephrotic range and the progression of the oedema (ascites preceding pedal oedema) did not support a renal aetiopathogenesis for the generalized oedema. Indeed, it is now known that persons with WD could have some degree of proximal tubulopathy, which may be partial (as may be the case in our patient) or generalized (Fanconi syndrome) [10, 11].
The neurological features of WD are primarily due to the deposition of copper in the lenticular nuclei, although areas like the brainstem and cerebellum can be affected . In our patient, neurologic features developed within three weeks of hepatic presentation, and in the absence of the use of copper chelating drugs. He had most of the neurologic features described in the literature: rigidity, dystonia, dysarthria, tremor at rest, festinant gait and insomnia [1, 12]. He was also emotionally labile with abrupt mood changes. Predominance of mood features in some patients explains the not uncommon presentation to psychiatrists . In the presence of significant hepatic derangement, we viewed the seizures he had in the early phase of his hospitalization as part of the clinical features of hepatic encephalopathy.
We used the scoring system proposed by the 8th International Meeting of Wilson Disease and Menkes Disease to make a definite diagnosis in our patient. A score of 4 or more makes the diagnosis of WD likely. This scoring system has been validated with high sensitivity and specificity as well as high positive and negative predictive values .
The long-term treatment of symptomatic cases of WD entails the chronic use of copper chelators and zinc, while liver transplantation provides a cure [1, 5]. The copper chelators commonly used for WD are penicillamine and trientine hydrochloride but these chelators are not available in Nigeria. While we attempt to source trientine abroad, we based our decision to commence a zinc-based treatment on a case series which showed favourable improvement in symptomatic children treated with zinc only .
We have described the second known case of WD in a Nigerian child, its rarity in the African population, and highlighted the varied clinical manifestations of the disease.
Written informed consent was obtained from the legal guardian of the patient for publication of this case report and accompanying image. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We wish to thank the residents in the Paediatric Neurology and Nephrology Unit of Lagos University Teaching Hospital who contributed to the in-hospital management of our patient.
- Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML: Wilson’s disease. Lancet. 2007, 369 (9559): 397-408. 10.1016/S0140-6736(07)60196-2.View ArticlePubMedGoogle Scholar
- Longe AC, Glew RH, Omene JA: Wilson’s disease. Report of a case in a Nigerian. Arch Neurol. 1982, 39 (2): 129-130. 10.1001/archneur.1982.00510140063018.View ArticlePubMedGoogle Scholar
- Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F: Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003, 23 (3): 139-142. 10.1034/j.1600-0676.2003.00824.x.View ArticlePubMedGoogle Scholar
- Saito T: Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987, 146 (3): 261-265. 10.1007/BF00716470.View ArticlePubMedGoogle Scholar
- Merle U, Schaefer M, Ferenci P, Stremmel W: Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut. 2007, 56 (1): 115-120. 10.1136/gut.2005.087262.View ArticlePubMedPubMed CentralGoogle Scholar
- Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R: Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology. 2010, 52 (6): 1948-1956. 10.1002/hep.23910.View ArticlePubMedGoogle Scholar
- Abdel Ghaffar TY, Elsayed SM, Elnaghy S, Shadeed A, Elsobky ES, Schmidt H: Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients. BMC Pediatr. 2011, 11: 56-10.1186/1471-2431-11-56.View ArticlePubMedPubMed CentralGoogle Scholar
- Cisse A, Morel Y, Coulibaly M, Souare IS, Cisse AF, Nabe A, Camara LM, Cisse B, Camara S, Bangoura SA, Sylla A, Dia H, Da Silva L: Wilson’s disease: study of 6 neurologic forms observed at the University Hospital in Conakry. Med Trop (Mars). 2004, 64 (1): 53-57.Google Scholar
- Dumas M, Girard PL, Jacquin-Cotton L, Konate S: 1st case of Wilson’s disease in Senegal. Bull Soc Med Afr Noire Lang Fr. 1970, 15 (1): 96-99.PubMedGoogle Scholar
- Sozeri E, Feist D, Ruder H, Scharer K: Proteinuria and other renal functions in Wilson’s disease. Pediatr Nephrol. 1997, 11 (3): 307-311. 10.1007/s004670050282.View ArticlePubMedGoogle Scholar
- Morgan HG, Stewart WK, Lowe KG, Stowers JM, Johnstone JH: Wilson’s disease and the Fanconi syndrome. Q J Med. 1962, 31: 361-384.PubMedGoogle Scholar
- Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, Vasudev MK, Swamy HS: Wilson’s disease: cranial MRI observations and clinical correlation. Neuroradiology. 2006, 48 (9): 613-621. 10.1007/s00234-006-0101-4.View ArticlePubMedGoogle Scholar
- Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, Carelli G, Nobili V: Treatment of Wilson’s disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med. 2005, 145 (3): 139-143. 10.1016/j.lab.2005.01.007.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.